TScan Therapeutics News

TScan Therapeutics | 10-Q: Quarterly report

May 13 07:34 ET

TScan Therapeutics | 8-K: TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 13 07:19 ET

TScan Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Louis Chrystal

May 3 16:07 ET

TScan Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Louis Chrystal

May 2 16:11 ET

TScan Therapeutics | DEFA14A: Others

Apr 30 16:56 ET

TScan Therapeutics | ARS: Annual Report to Security Holders

Apr 30 16:36 ET

TScan Therapeutics | DEF 14A: Definitive information statements

Apr 30 16:13 ET

TScan Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Cormorant Global Healthcare Master Fund, LP(5.15%),Cormorant Global Healthcare GP, LLC(5.15%), etc.

Apr 29 16:04 ET

TScan Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(6.1%),Baker Bros. Advisors (GP) LLC(6.1%), etc.

Apr 23 16:30 ET

TScan Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP

Apr 23 16:21 ET

TScan Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Lynx1 Capital Management LP

Apr 23 16:20 ET

TScan Therapeutics | 424B5: Prospectus

Apr 18 06:06 ET

TScan Therapeutics | 8-K: Current report

Apr 17 06:28 ET

TScan Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Apr 17 06:23 ET

TScan Therapeutics | 424B5: Prospectus

Apr 16 17:26 ET

TScan Therapeutics | 8-K: Current report

Apr 16 16:21 ET

TScan Therapeutics | EFFECT: Others

Apr 15 06:23 ET

TScan Therapeutics | CORRESP: CORRESP

Apr 10 14:25 ET

TScan Therapeutics | 10-K/A: Annual report (Amendment)

Apr 10 07:32 ET

TScan Therapeutics | 8-K: Current report

Apr 8 08:22 ET